Department of Gastrointestinal Endoscopy, Instituto Nacional de Cancerología México, DF, México.
Rev Esp Enferm Dig. 2012 Apr;104(4):185-9. doi: 10.4321/s1130-01082012000400003.
gastric cancer patients are first diagnosed with an unresectable tumor in up to 40% of cases. Gastric outlet obstruction causes nausea, vomiting, dehydration and malnutrition. The aim of the study was to compare self-expanding metal stents to antrectomy and Roux-en Y gastrojejunostomy for palliation of obstructive adenocarcinoma of the gastric antrum.
retrospective study in patients with obstructing cancer of the gastric antrum. Patients were divided into two groups: group A, underwent endoscopic placement of self-expanding metal stents and group B underwent surgical treatment with antrectomy and Roux-en Y gastrojejunostomy. Collected data included: age, gender, performance status (Karnofsky's score), body mass index, histopathology, clinical stage (TNM classification), technical and clinical success of the procedure, time to oral intake, in-hospital stay, reintervention rate, and complications related to the treatment and survival.
a total of 39 patients with gastric adenocarcinoma were included, 21 male and 18 female. Nineteen patients were assigned to group A and 20 patients to group B. There were no statistically significant differences between groups in regards to age, body mass index, Karnofsky's score and clinical stage. The technical and clinical success was similar for both groups. There was a statistically significant difference between groups favoring self-expanding metal stent in time to oral intake (1 ± 0 vs. 4.9 ± 0.6 days, p = 0.0001) and in-hospital stay (0.94 ± 1.18 vs. 7.8 ± 7.7 days, p = 0.0005). We did not find statistically significant differences with regards to long-term survival.
in patients with malignant gastric outlet obstruction due to gastric cancer, endoscopic palliation with self-expanding metal stents provide a shorter interval to oral intake, shorter in-hospital stay and lower rate of complications.
多达 40%的胃癌患者在首次诊断时就被发现肿瘤无法切除。胃出口梗阻会导致恶心、呕吐、脱水和营养不良。本研究旨在比较自膨式金属支架与胃切除术和 Roux-en-Y 胃空肠吻合术治疗胃窦腺癌引起的梗阻性疾病。
回顾性研究患有胃窦部梗阻性癌症的患者。患者分为两组:A 组,行内镜下自膨式金属支架置入术;B 组,行胃切除术和 Roux-en-Y 胃空肠吻合术。收集的数据包括:年龄、性别、身体状况(卡诺夫斯基评分)、体重指数、组织病理学、临床分期(TNM 分类)、操作的技术和临床成功率、开始口服摄入的时间、住院时间、再干预率、与治疗和生存相关的并发症。
共纳入 39 例胃腺癌患者,男 21 例,女 18 例。19 例患者被分配到 A 组,20 例患者被分配到 B 组。两组在年龄、体重指数、卡诺夫斯基评分和临床分期方面无统计学差异。两组的技术和临床成功率相似。两组在开始口服摄入时间(1±0 比 4.9±0.6 天,p=0.0001)和住院时间(0.94±1.18 比 7.8±7.7 天,p=0.0005)方面存在统计学差异,且 A 组优于 B 组。我们没有发现与长期生存相关的统计学差异。
在因胃癌引起的恶性胃出口梗阻患者中,内镜下自膨式金属支架姑息治疗可缩短开始口服摄入的时间、住院时间,降低并发症发生率。